Daratumumab-induced transient myopic shift
Purpose: To describe an unprecedented case of transient myopic shift induced by a chemotherapeutic agent, daratumumab. Observations: A 43-year-old emmetropic female with multiple myeloma experienced sudden onset of myopic shift during her first intravenous dose of daratumumab, an increasingly common...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-03-01
|
Series: | American Journal of Ophthalmology Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451993618301750 |